Rheumatoid arthritis associated interstitial lung disease in KwaZulu-Natal, South Africa: Clinical profile and treatment outcomes Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020
Trends in cystic fibrosis (CF) survival in South Africa over 40 years Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe Source: ERJ Open Res, 7 (4) 00411-2021; 10.1183/23120541.00411-2021 Year: 2021
Evidence incidence of cystic fibrosis: A 30-year study in Krasnoyarsk, Russia Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013
The changing epidemiology of cystic fibrosis in Italy: data from the Italian registry Source: Eur Respir J 2002; 20: Suppl. 38, 340s Year: 2002
Interstitial lung disease: specific issues in the Far East Source: Eur Respir Mon; 2009: 46: 375–385 Year: 2009
Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis Source: Eur Respir J, 50 (2) 1700763; 10.1183/13993003.00763-2017 Year: 2017
Clinical features of adult’s cystic fibrosis in the Republic of Belarus Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
Population surveillance in North West Adelaide: the impact of diagnosed and undiagnosed chronic obstructive pulmonary disease (COPD) on quality of life Source: Eur Respir J 2005; 26: Suppl. 49, 383s Year: 2005
Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016
Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case–control study Source: ERJ Open Res, 5 (4) 00001-2019; 10.1183/23120541.00001-2019 Year: 2019
Population surveillance in North West Adelaide - burden of respiratory disease Source: Annual Congress 2005 - Information for the active clinician Year: 2005
Population surveillance in North West Adelaide: physical activity associated with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 383s Year: 2005
Cystic fibrosis mortality and survival in the UK: 1947-2003 Source: Eur Respir J 2007; 29: 522-526 Year: 2007
Cystic fibrosis diagnosis in adulthood as a result of study of relatives within the newborn screening programme Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015
Prevalence of asymptomatic bronchiectasis and associations among the health screening population in South Korea Source: ERJ Open Res, 7 (3) 00188-2021; 10.1183/23120541.00188-2021 Year: 2021
Non-cystic fibrosis bronchiectasis: etiology and predictors of exacerbations and mortality in patients across the largest health system in central and western Massachusetts Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017
Course of disease and cause of death in patients with idiopathic pulmonary fibrosis in Eastern Finland Source: International Congress 2015 – IPF: clinical aspects Year: 2015
Longitudinal non-cystic fibrosis trends of pulmonary Mycobacterium abscessus disease from 2010 to 2017: spread of the “globally successful clone” in Asia Source: ERJ Open Res, 7 (1) 00191-2020; 10.1183/23120541.00191-2020 Year: 2021